Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP by country
Countries reporting
24
Highest
20
Cyprus
Lowest
0
Denmark
Median
0.7723
Years covered
10
2009–2018
Data points
246
What the numbers show
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP is currently reported for 24 countries. The highest value is 20 in Cyprus; the lowest is 0 in Denmark.
The median across all reporting countries is 0.7723, and the mean is 2.75.
Proportion of isolates with decreased susceptibility or resistance: full country ranking
| # | Country | Latest | Year | 10-year change | Trend |
|---|---|---|---|---|---|
| 1 | Cyprus | 20 | 2018 | down 60.0% | volatile |
| 2 | Belarus | 15.8 | 2018 | — | volatile |
| 3 | Greece | 6 | 2018 | — | volatile |
| 4 | Italy | 5 | 2018 | down 73.1% | volatile |
| 5 | Spain | 4.8 | 2018 | — | volatile |
| 6 | Austria | 3.4 | 2018 | down 83.9% | volatile |
| 7 | Belgium | 2.9 | 2018 | down 54.4% | volatile |
| 8 | Hungary | 2.2 | 2018 | — | volatile |
| 9 | Sweden | 1.5 | 2018 | down 46.0% | volatile |
| 10 | Poland | 1.4 | 2018 | — | volatile |
| 11 | United Kingdom of Great Britain and Northern Ireland | 1.2 | 2018 | — | volatile |
| 12 | Germany | 1 | 2018 | down 55.0% | volatile |
| 13 | Canada | 0.5445 | 2018 | down 51.7% | volatile |
| 14 | United States of America | 0.2907 | 2018 | down 63.6% | volatile |
| 15 | Latvia | 0 | 2018 | — | volatile |
| 15 | Malta | 0 | 2018 | — | volatile |
| 15 | Netherlands | 0 | 2018 | down 100.0% | volatile |
| 15 | Norway | 0 | 2018 | down 100.0% | volatile |
| 15 | Ireland | 0 | 2018 | down 100.0% | volatile |
| 15 | Portugal | 0 | 2018 | — | volatile |
| 15 | Slovakia | 0 | 2018 | — | volatile |
| 15 | Slovenia | 0 | 2018 | down 100.0% | volatile |
| 15 | France | 0 | 2018 | down 100.0% | volatile |
| 15 | Denmark | 0 | 2018 | down 100.0% | volatile |